|
 |
European BioPharmaceutical Review
|
"There's one thing I am certain of... Saxony will soon be Germany's main biotechnology centre..." - Professor Guenter Blobel (Nobel Prize for Medicine, 1999)
Should every nation, state, city, town and village develop their own biotechnology cluster? What is biosaxony and how could it possibly be different from the many other bio-locations? As you read this article, hopefully you will agree that there are unique elements to biosaxony that justify taking a closer look. First there are the people; the ready availability of a highly trained and motivated workforce with (together with Portugal) the lowest labour rates in Europe. Rates will stay low as Eastern Europe opens up in 2004 and the availability of skilled labour is further supplemented.
Next there is the infrastructure - the most modern in Europe with 100 per cent digital communication systems and fibre-optic networks, gas, electricity and waste disposal functionality at green field locations, as well as modern roads, airports and rail networks which have all been rebuilt within the last 10 years.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Line Clearance in Pharmaceutical Packaging & Manufacturing
5 February 2009, Manchester, UK
More info >>
|
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
